Boston Scientific's decision to stop selling coaptite boosts Axonics stock as investors see it as a move to ease ...

Boston Scientific Corporation BSX recently received ... bradycardia pacing and were supplemented with bench testing and ...

On Monday, Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $84.41 which represents a decrease of $-0.13 or -0.15% from the prior close of $84.54. The stock opened at $84.38 ...

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Boston Scientific (BSX – Research ...

Boston Scientific (NYSE: BSX) has more than doubled in value since early January 2021 – jumping from levels of $36 then to around $82 now – vs. an increase of about 45% for the S&P 500 over ...

Recommended Reading Boston Scientific buys Silk Road Medical for $1.26B UPDATE: Sept. 17, 2024: Boston Scientific said Tuesday that it has closed its acquisition of Silk Road Medical, completing ...

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Boston Scientific Corp. (Symbol: BSX) has taken over the #24 spot from NVIDIA Corp ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Boston Scientific (BSX) closed at $81.79 in the latest trading session, marking a +1.39% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 1.01% for the day.

MARLBOROUGH, Mass., Sept. 17, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Silk Road Medical, Inc. (Nasdaq: SILK), a medical ...

(RTTNews) - Medical technology company Boston Scientific Corp. (BSX) announced Tuesday the close of its acquisition of medical device company Silk Road Medical, Inc. (SILK) for $27.50 per share in ...